Research retractions are not all misconduct, and a leaderboard is not a verdict. The Retraction Watch database leaderboard, updated August 2026, shows researchers with dozens or hundreds of retractions but also cautions that its ranking is unofficial and shaped by what can be verified. Its treatment of the landmark 1980s case involving a Harvard University cardiologist illustrates why raw counts require context. Nonetheless, these cases expose recurring vulnerabilities that every research team should address.
Fabrication and falsification
The clearest danger is inventing or manipulating data such that the research publication does not reflect the truth. The U.S. Office of Research Integrity defines research misconduct as fabrication, falsification, or plagiarism in proposing, performing, reviewing, or reporting research. Researchers must mitigate errors before data analysis. We must preserve raw data, maintain audit trails, document exclusions, preregister key methods when appropriate, and independently verify critical findings.
Peer-review manipulation
Fake reviewer identities, deceptive reviewer contact information, undisclosed conflicts, or coordinated review arrangements can compromise editorial decisions. Researchers should never control review through false identities or reciprocal schemes. Journals should verify reviewer identities and conflicts. The Committee on Publication Ethics (COPE)’s retraction guidance emphasizes evidence-based, transparent editorial processes when published work is unreliable or publication integrity is compromised.
Image and data integrity
A duplicated microscopy panel, altered gel, recycled figure, unexplained statistical inconsistency, or dataset that cannot be traced to source files can undermine an otherwise valuable study. Researchers should retain original files, document permitted image adjustments, version-control datasets, and conduct a pre-submission integrity review. We must ensure that every figure and key analysis is reproducible from preserved source data.
Real physician voices, twice a week
Free, and one click to unsubscribe.
Ethics violations
Ethics approval is not an administrative formality. Human-subject research requires valid oversight, appropriate consent, protocol adherence, and accurate reporting of what the approving body authorized. COPE emphasizes that retraction can be appropriate when findings are unreliable or when there is evidence of unethical research. Researchers should archive approvals and amendments. We should reconcile them with manuscripts and stop or clarify activity when authorization is uncertain.
Plagiarism and duplication
Distorting the scientific record can occur from recycling data without disclosure, fragmenting one dataset into misleading publications, or republishing substantially the same work. Researchers must not copy text without attribution or referencing. Plagiarism is explicitly included in the definition of research misconduct. Similarity software can help, but researcher judgment remains essential. Authors should cite prior dissemination. We must disclose overlapping samples and datasets to editors.
Coauthor and editorial-associated retractions
The landmark 1980s case involving a Harvard University cardiologist’s retractions remains instructive because its consequences extended beyond one researcher. Contemporary accounts in the Retraction Watch database described extensive fabrication and raised concerns about supervision, coauthor responsibility, and institutional oversight. Thus, authorship requires accountability, not decoration. Every author should understand the study, review the manuscript, verify contributions and disclosures, and know where the underlying evidence resides.
Practical lesson
The practical lesson is simple. We must build integrity into the research system rather than relying on reputation or trust alone. Before submitting or presenting research, we should use an “integrity pause” to confirm the protocol, ethics approval, raw data, figures, analyses, authorship, disclosures, citations, and reviewer suggestions. Retraction helps correct the literature. However, prevention is better. Prevention protects patients, collaborators, institutions, and careers.
Olumuyiwa Bamgbade is an accomplished health care leader with a strong focus on value-based health care delivery. A specialist physician with extensive training across Nigeria, the United Kingdom, the United States, and South Korea, Dr. Bamgbade brings a global perspective to clinical practice and health systems innovation.
He serves as an adjunct professor at academic institutions across Africa, Europe, and North America and has published 45 peer-reviewed scientific papers in PubMed-indexed journals. His global research collaborations span more than 20 countries, including Nigeria, Australia, Iran, Mozambique, Rwanda, Kenya, Armenia, South Africa, the U.K., China, Ethiopia, and the U.S.
Dr. Bamgbade is the director of Salem Pain Clinic in Surrey, British Columbia, Canada—a specialist and research-focused clinic. His work at the clinic centers on pain management, health equity, injury rehabilitation, neuropathy, insomnia, societal safety, substance misuse, medical sociology, public health, medicolegal science, and perioperative care.
